Rising incidence of cardiovascular diseases and increasing geriatric population are significant factor driving global interventional cardiology devices market growth.
Vancouver, BC -- (SBWIRE) -- 04/14/2021 -- The Global Interventional Cardiology Devices Market study includes a profound analysis of this business sphere focusing on the overall remuneration over the projected period, as well as scrutinizing every single industry segment at length. It is further inclusive of significant information related to the industry size and the current market scenario. The report presents an overview of the key drivers, opportunities, and restraints of the market, which clearly define its position on a global level. Furthermore, detailed insights into the geographical spectrum of the market and a concise study of the key market contenders are among the most prominent components of the global Interventional Cardiology Devices market report.
Rising incidence of cardiovascular diseases result in an increase in healthcare expenditure, which in turn, is driving revenue growth of the interventional cardiology devices market. According to the Centers for Disease Control and Prevention, heart attacks account for over USD 320.00 Billion in yearly healthcare expenditure and lost productivity, and this figure is expected to reach USD 818.00 Billion in 2030.
To get a sample copy of the Global Interventional Cardiology Devices Market report, visit @ https://www.emergenresearch.com/request-sample/570
Some Key Highlights in the Report
In June 2019, Terumo Corporation signed a partnership agreement with Orchestra BioMed, Inc. This partnership provides Terumo Corporation with exclusive rights for the development and marketing of Virtue Sirolimus-Eluting Balloon (SEB).
Angioplasty stents find application to restore blood flow occurring due to blockage and to reduce heart attack risk. Stents are considered beneficial in reducing damage caused to heart muscles in the event of a heart attack. Also, stents may instantly relieve or reduce symptoms comprising chest pain, fatigue, and shortness of breath.
Among the end-use segments, the hospitals segment accounted for largest revenue share in 2020, which can be attributed to robust presence of experienced healthcare professionals for installation of interventional cardiology devices and more advanced and developed healthcare infrastructure, along with high purchasing power for advanced and dedicated interventional cardiology devices in countries in the region. Additionally, hospitals account for adverse event minimization in patients during critical procedures, including stent installation and cardiac catheterization.
Key players in the market include Abbott Laboratories, Terumo Corporation, iVascular, Boston Scientific Corporation, Edwards Lifesciences Corporation, B.Braun Melsungen, Medtronic PLC, Koninklijke Philips NV, Biosensors International Group Ltd., and Endocor GmbH.
Interventional Cardiology Devices Market Segmentation:
Emergen Research has segmented the global interventional cardiology devices market on the basis of product type, end-use, and region:
Product Type Outlook (Revenue, USD Billion; 2018–2028)
Angioplasty Stents
Angioplasty Balloons
Catheters
Structural Heart Devices
Plaque Modification Devices
Guidewires
Hemodynamic Flow Alteration Devices
Others
End-Use Outlook (Revenue, USD Billion; 2018–2028)
Hospitals
Ambulatory Surgical Centers
Others
Key Regions analyzed in the report include:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
AsiaPacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/570
Elucidating the competitive scenario of the Global Interventional Cardiology Devices Market:
The comprehensive global Interventional Cardiology Devices market analysis includes meaningful insights into the competitive spectrum of this business sphere. It goes on to enlist the detailed profiles of each market competitor.
The latest report includes the industry share, production facilities, development prospects,and geographies served by each market player.
The study also showcases the extensive product portfolios of the prominent market contenders and offers critical data and information about the application scope, as well as specifications of these products.
In addition, the study presents the fundamental market insights, pricing range of products offered by these companies, and the gross profits and losses experienced by these players throughout their market tenures.
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2020-2028
Chapter 3. Key Insights
Chapter 4. Interventional Cardiology Devices Market Segmentation & Impact Analysis
4.1. Interventional Cardiology Devices Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers' analysis
4.2.2.1. Rising incidence of cardiovascular diseases
4.2.2.2. Increasing prevalence of obesity
4.2.2.3. Advancement in technology
4.2.2.4. Growing demand for minimally invasive treatment
4.2.3. Market restraints analysis
4.2.3.1. Availability of substitutes
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter's Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Interventional Cardiology Devices Market By Product Type Insights & Trends, Revenue (USD Billion)
5.1. Product Type Dynamics & Market Share, 2021 & 2028
5.1.1. Angioplasty Stents
5.1.2. Angioplasty Balloons
5.1.3. Catheters
5.1.4. Structural Heart Devices
5.1.5. Plaque Modification Devices
5.1.6. Guidewires
5.1.7. Hemodynamic Flow Alteration Devices
5.1.8. Others
Chapter 6. Interventional Cardiology Devices Market By End-Use Insights & Trends, Revenue (USD Billion)
6.1. End-Use Dynamics & Market Share, 2021 & 2028
6.1.1. Hospitals
6.1.2. Ambulatory Surgical Centers
6.1.3. Others
CONTINUED..!!
For more details on the Global Interventional Cardiology Devices Market report, visit @ https://www.emergenresearch.com/industry-report/interventional-cardiology-devices-market
Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure your queries are solved, and the report is customized to meet your requirements.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
Read Full Press Release: https://www.emergenresearch.com/press-release/global-interventional-cardiology-devices-market